The NYSDOH AIDS Institute in partnership with Alliance for Positive Health, and Champlain Valley Physicians Hospital is sponsoring a free Buprenorphine Waiver Eligibility Training for Clinical Providers. In response to opioid overdose deaths in New York State, increased access to buprenorphine treatment for opioid use disorder is urgently needed. Physicians, Nurse Practitioners, Physician Assistants and Medical Residents are welcome to attend.
Under current regulations, authorized practitioners (MDs, DOs, NPs & PAs) are required to obtain a ‘waiver’ to prescribe buprenorphine. To acquire this waiver, physicians are required to complete a standardized buprenorphine waiver 8-hour training. Nurse Practitioners (NPs) and Physician Assistants (PAs) are required to complete the standardized buprenorphine waiver 8-hour training as well as an additional 16 hours of online training as established by the Comprehensive Addiction and Recovery Act (CARA). Residents may also take the course and apply for their waiver once they receive their DEA license. The buprenorphine waiver 8-hour training is offered in a ‘half and-half’ format [4.5 hours of in-person training followed up by 3.5 hours of online training]. Upon completion of the required training, providers will meet the requirement of the DATA 2000 to apply for a waiver to prescribe buprenorphine for opioid-dependent patients. Please contact us for further information.
CME CREDITS: The University of Rochester School of Medicine and Dentistry designates this live activity for a maximum of 4.50 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Rochester School of Medicine and Dentistry is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Trainers: Ross Sullivan, MD, SUNY Upstate Medical University, Syracuse, NY
Justine Waldman, MD, REACH Medical, Ithaca, NY
Location: Champlain Valley Physicians Hospital (CVPH), 75 Beekman St, Board Room, Plattsburgh, NY 12901.
Directions: https://goo.gl/maps/xRbkCKPHUQU2
Questions: NYSDOH, AIDS Institute, Office of Drug User Health
Belinda Duncan, 212-417-4553, buprenorphine@health.ny.gov
ACCREDITATION: This activity has been planned and implemented by NYSDOH, AIDS Institute in accordance with the accreditation requirements and policies of the American Academy of Addiction Psychiatry (AAAP) and in partnership with Alliance for Positive Health, and Champlain Valley Physicians Hospital.
Funding for this course was made possible (in part) by 1U79TI026556 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. American Academy of Addiction Psychiatry is the sponsoring data organization.
This training is supported by 1 NU17CE002742 (Prescription Drug Overdose Prevention), funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services.
